Health tech company MyFiziq (ASX: MYQ) is making rapid inroads into the lucrative health-conscious Chinese market having signed terms with…
The world’s most lucrative healthcare market is quickly appreciating Aussie pharmaceuticals company Pharmaxis (ASX: PXS) whose cystic fibrosis (CF) treatment…
Vowing to look after themselves better in the wake of a pandemic, Australians are keenly focused on their personal health…
With 13.2 million Australians suffering from long term eye problems, the rationale behind Healthia’s (ASX: HLA) $43m acquisition of The…
Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted…
Is the notion of the typical Australian stacking on the ‘isobars’ and indulging in a few too many ‘lockdown lagers’…